Synopsis
Synopsis
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Mammol (tn)
2. Bismuth Subnitrate (jp17/usp)
3. Chebi:31293
4. D01642
5. Q27114265
| Molecular Weight | 397.01 g/mol |
|---|---|
| Molecular Formula | BiH2N3O9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 396.95950 g/mol |
| Monoisotopic Mass | 396.95950 g/mol |
| Topological Polar Surface Area | 161 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 164 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
27
PharmaCompass offers a list of Bismuth Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bismuth Nitrate manufacturer or Bismuth Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bismuth Nitrate manufacturer or Bismuth Nitrate supplier.
PharmaCompass also assists you with knowing the Bismuth Nitrate API Price utilized in the formulation of products. Bismuth Nitrate API Price is not always fixed or binding as the Bismuth Nitrate Price is obtained through a variety of data sources. The Bismuth Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mammol Tn manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mammol Tn, including repackagers and relabelers. The FDA regulates Mammol Tn manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mammol Tn API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mammol Tn manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mammol Tn supplier is an individual or a company that provides Mammol Tn active pharmaceutical ingredient (API) or Mammol Tn finished formulations upon request. The Mammol Tn suppliers may include Mammol Tn API manufacturers, exporters, distributors and traders.
click here to find a list of Mammol Tn suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mammol Tn DMF (Drug Master File) is a document detailing the whole manufacturing process of Mammol Tn active pharmaceutical ingredient (API) in detail. Different forms of Mammol Tn DMFs exist exist since differing nations have different regulations, such as Mammol Tn USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mammol Tn DMF submitted to regulatory agencies in the US is known as a USDMF. Mammol Tn USDMF includes data on Mammol Tn's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mammol Tn USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mammol Tn suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mammol Tn Drug Master File in Japan (Mammol Tn JDMF) empowers Mammol Tn API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mammol Tn JDMF during the approval evaluation for pharmaceutical products. At the time of Mammol Tn JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mammol Tn suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mammol Tn Drug Master File in Korea (Mammol Tn KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mammol Tn. The MFDS reviews the Mammol Tn KDMF as part of the drug registration process and uses the information provided in the Mammol Tn KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mammol Tn KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mammol Tn API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mammol Tn suppliers with KDMF on PharmaCompass.
A Mammol Tn CEP of the European Pharmacopoeia monograph is often referred to as a Mammol Tn Certificate of Suitability (COS). The purpose of a Mammol Tn CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mammol Tn EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mammol Tn to their clients by showing that a Mammol Tn CEP has been issued for it. The manufacturer submits a Mammol Tn CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mammol Tn CEP holder for the record. Additionally, the data presented in the Mammol Tn CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mammol Tn DMF.
A Mammol Tn CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mammol Tn CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mammol Tn suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mammol Tn as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mammol Tn API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mammol Tn as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mammol Tn and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mammol Tn NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mammol Tn suppliers with NDC on PharmaCompass.
Mammol Tn Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mammol Tn GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mammol Tn GMP manufacturer or Mammol Tn GMP API supplier for your needs.
A Mammol Tn CoA (Certificate of Analysis) is a formal document that attests to Mammol Tn's compliance with Mammol Tn specifications and serves as a tool for batch-level quality control.
Mammol Tn CoA mostly includes findings from lab analyses of a specific batch. For each Mammol Tn CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mammol Tn may be tested according to a variety of international standards, such as European Pharmacopoeia (Mammol Tn EP), Mammol Tn JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mammol Tn USP).